Skip to main content

Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma Cover

.blurhash-client-img { display: none !important; }

Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma

Radiology and Oncology

Volume 41 (2007): Issue 1 (March 2007)

By: Barbara Novaković, Vladimir Kotnik, Tanja Šetina, Marjeta Vovk and Srdjan Novaković

Open Access

|Apr 2007

Download Article

Download the full article as a PDF file.

Articles in this issue

DOI: https://doi.org/10.2478/v10019-007-0004-y | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 23 - 32

Published on: Apr 30, 2007

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

B-cell - therapy,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2007 Barbara Novaković, Vladimir Kotnik, Tanja Šetina, Marjeta Vovk, Srdjan Novaković, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 41 (2007): Issue 1 (March 2007)